Activating brown adipose tissue for weight loss and lowering of blood glucose levels: A microPET study using obese and diabetic model mice

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Wu, Chenxi ^a   Cheng, Wuying ^a   Sun, Yi ^a   Dang, Yonghong ^a   Gong, Fengying ^a   Zhu, Huijuan ^a   Li, Naishi ^a   Li, Fang ^a   Zhu, Zhaohui ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

4 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL]PHENOXYACETIC ACID; FLUORODEOXYGLUCOSE F 18; GLUCOSE; LEVOTHYROXINE SODIUM; STREPTOZOCIN; GLUCOSE BLOOD LEVEL; INSULIN;

ADIPOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BROWN ADIPOSE TISSUE; CONTROLLED STUDY; DIABETIC OBESITY; DRUG MECHANISM; DRUG UPTAKE; EMISSION TOMOGRAPHY; EX VIVO STUDY; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; IN VIVO STUDY; MALE; MICRO POSITRON EMISSION TOMOGRAPHY; MOUSE; MOUSE MODEL; NONHUMAN; OBESITY; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TREATMENT DURATION; TREATMENT OUTCOME; WEIGHT REDUCTION; ANIMAL; DIABETES MELLITUS; DIABETES MELLITUS, EXPERIMENTAL; DRUG EFFECTS; HUMAN; LIPID DIET; METABOLISM; MOUSE MUTANT; NONOBESE DIABETIC MOUSE; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY;

MUS;

ADIPOSE TISSUE, BROWN; ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS; DIABETES MELLITUS, EXPERIMENTAL; DIET, HIGH-FAT; FLUORODEOXYGLUCOSE F18; HUMANS; INSULIN; MICE; MICE, INBRED NOD; MICE, OBESE; OBESITY; POSITRON-EMISSION TOMOGRAPHY; WEIGHT LOSS;

EID: 84914689252     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0113742     Document Type: Article

References (40)

1. Cypess AM, Lehman S, Williams G, Tal I, Rodman D, et al. (2009) Identification and importance of brown adipose tissue in adult humans. N Engl J Med 360: 1509-1517.
2. Saito M, Okamatsu-Ogura Y, Matsushita M, Watanabe K, Yoneshiro T, et al. (2009) High incidence of metabolically active brown adipose tissue in healthy adult humans: effects of cold exposure and adiposity. Diabetes 58: 1526-1531.
3. Cheng W, Zhu Z, Jin X, Chen L, Zhuang H, et al. (2012) Intense FDG activity in the brown adipose tissue in omental and mesenteric regions in a patient with malignant pheochromocytoma. Clin Nucl Med 37: 514-515.
4. Bartelt A, Bruns OT, Reimer R, Hohenberg H, Ittrich H, et al. (2011) Brown adipose tissue activity controls triglyceride clearance. Nat Med 17: 200-205.
5. Heaton GM, Wagenvoord RJ, Kemp A Jr, Nicholls DG (1978) Brown-adipose-tissue mitochondria: photoaffinity labelling of the regulatory site of energy dissipation. Eur J Biochem 82: 515-521.
6. Cypess AM, Kahn CR (2010) Brown fat as a therapy for obesity and diabetes. Curr Opin Endocrinol Diabetes Obes 17: 143-149.
7. Seale P, Lazar MA (2009) Brown fat in humans: turning up the heat on obesity. Diabetes 58: 1482-1484.
8. Sacks H, Symonds ME (2013) Anatomical locations of human brown adipose tissue: functional relevance and implications in obesity and type 2 diabetes. Diabetes 62: 1783-1790.
9. Nedergaard J, Cannon B (2010) The changed metabolic world with human brown adipose tissue: therapeutic visions. Cell Metab 11: 268-272.
10. van Marken Lichtenbelt WD, Vanhommerig JW, Smulders NM, Drossaerts JM, Kemerink GJ, et al. (2009) Cold-activated brown adipose tissue in healthy men. N Engl J Med 360: 1500-1508.
11. Feldmann HM, Golozoubova V, Cannon B, Nedergaard J (2009) UCP1 ablation induces obesity and abolishes diet-induced thermogenesis in mice exempt from thermal stress by living at thermoneutrality. Cell Metab 9: 203-209.
12. Kontani Y, Wang Y, Kimura K, Inokuma KI, Saito M, et al. (2005) UCP1 deficiency increases susceptibility to diet-induced obesity with age. Aging Cell 4: 147-155.
13. Gavrilova O, Marcus-Samuels B, Graham D, Kim JK, Shulman GI, et al. (2000) Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice. J Clin Invest 105: 271-278.
14. Vosselman MJ, van Marken Lichtenbelt WD, Schrauwen P (2013) Energy dissipation in brown adipose tissue: From mice to men. Mol Cell Endocrinol.
15. Vijgen GH, Bouvy ND, Teule GJ, Brans B, Hoeks J, et al. (2012) Increase in brown adipose tissue activity after weight loss in morbidly obese subjects. J Clin Endocrinol Metab 97: E1229-1233.
16. Jacene HA, Cohade CC, Zhang Z, Wahl RL (2011) The relationship between patients' serum glucose levels and metabolically active brown adipose tissue detected by PET/CT. Mol Imaging Biol 13: 1278-1283.
17. Wu C, Cheng W, Xing H, Dang Y, Li F, et al. (2011) Brown adipose tissue can be activated or inhibited within an hour before 18F-FDG injection: a preliminary study with microPET. J Biomed Biotechnol 2011: 159834.
18. Granneman JG (1990) Norepinephrine and BRL 37344 stimulate adenylate cyclase by different receptors in rat brown adipose tissue. J Pharmacol Exp Ther 254: 508-513.
19. Bianco AC, McAninch EA (2013) The role of thyroid hormone and brown adipose tissue in energy homoeostasis. Lancet Diabetes Endocrinol 1: 250-258.
20. Vijgen GH, Bouvy ND, Teule GJ, Brans B, Schrauwen P, et al. (2011) Brown adipose tissue in morbidly obese subjects. PLoS One 6: e17247.
21. Williams G, Kolodny GM (2008) Method for decreasing uptake of 18F-FDG by hypermetabolic brown adipose tissue on PET. AJR Am J Roentgenol 190: 1406-1409.
22. Samuel VT, Shulman GI (2012) Mechanisms for insulin resistance: common threads and missing links. Cell 148: 852-871.
23. Richardson JM, Balon TW, Treadway JL, Pessin JE (1991) Differential regulation of glucose transporter activity and expression in red and white skeletal muscle. J Biol Chem 266: 12690-12694.
24. Vasilijevic A, Vojcic L, Dinulovic I, Buzadzic B, Korac A, et al. (2010) Expression pattern of thermogenesis-related factors in interscapular brown adipose tissue of alloxan-treated rats: beneficial effect of L-arginine. Nitric Oxide 23: 42-50.
25. Wijers SL, Schrauwen P, van Baak MA, Saris WH, van Marken Lichtenbelt WD (2011) Beta-adrenergic receptor blockade does not inhibit cold-induced thermogenesis in humans: possible involvement of brown adipose tissue. J Clin Endocrinol Metab 96: E598-605.
26. Nisoli E, Tonello C, Benarese M, Carruba MO (1995) Rat frontal cortex beta 1-adrenoceptors are activated by the beta 3-adrenoceptor agonists SR 58611A and SR 58878A but not by BRL 37344 or ICI 215,001. J Neurochem 65: 1580-1587.
27. Suarez J, Rivera P, Arrabal S, Crespillo A, Serrano A, et al. (2014) Oleoylethanolamide enhances beta-adrenergic-mediated thermogenesis and white-to-brown adipocyte phenotype in epididymal white adipose tissue in rat. Dis Model Mech 7: 129-141.
28. Williams CA, Shih MF, Taberner PV (1999) Sustained improvement in glucose homeostasis in lean and obese mice following chronic administration of the beta 3 agonist SR 58611A. Br J Pharmacol 128: 1586-1592.
29. Liu X, Perusse F, Bukowiecki LJ (1998) Mechanisms of the antidiabetic effects of the beta 3-adrenergic agonist CL-316243 in obese Zucker-ZDF rats. Am J Physiol 274: R1212-1219.
30. Masuo K, Lambert GW (2011) Relationships of adrenoceptor polymorphisms with obesity. J Obes 2011: 609485.
31. Bhadada SV, Patel BM, Mehta AA, Goyal RK (2011) beta(3) Receptors: Role in Cardiometabolic Disorders. Ther Adv Endocrinol Metab 2: 65-79.
32. Esler M, Rumantir M, Wiesner G, Kaye D, Hastings J, et al. (2001) Sympathetic nervous system and insulin resistance: from obesity to diabetes. American journal of hypertension 14: 304S-309S.
33. Straznicky NE, Eikelis N, Nestel PJ, Dixon JB, Dawood T, et al. (2012) Baseline sympathetic nervous system activity predicts dietary weight loss in obese metabolic syndrome subjects. J Clin Endocrinol Metab 97: 605-613.
34. Cannon B, Nedergaard J (2004) Brown adipose tissue: function and physiological significance. Physiol Rev 84: 277-359.
35. Kaptein EM, Beale E, Chan LS (2009) Thyroid hormone therapy for obesity and nonthyroidal illnesses: a systematic review. J Clin Endocrinol Metab 94: 3663-3675.
36. Bredella MA, Fazeli PK, Freedman LM, Calder G, Lee H, et al. (2012) Young women with cold-activated brown adipose tissue have higher bone mineral density and lower Pref-1 than women without brown adipose tissue: a study in women with anorexia nervosa, women recovered from anorexia nervosa, and normal-weight women. J Clin Endocrinol Metab 97: E584-590.
37. Dora JM, Machado WE, Rheinheimer J, Crispim D, Maia AL (2010) Association of the type 2 deiodinase Thr92Ala polymorphism with type 2 diabetes: case-control study and meta-analysis. Eur J Endocrinol 163: 427-434.
38. Villarroya F, Vidal-Puig A (2013) Beyond the sympathetic tone: the new brown fat activators. Cell Metab 17: 638-643.
39. Fueger BJ, Czernin J, Hildebrandt I, Tran C, Halpern BS, et al. (2006) Impact of animal handling on the results of 18F-FDG PET studies in mice. J Nucl Med 47: 999-1006.
40. Drubach LA, Palmer EL 3rd, Connolly LP, Baker A, Zurakowski D, et al. (2011) Pediatric brown adipose tissue: detection, epidemiology, and differences from adults. J Pediatr 159: 939-944.